AMRX · Amneal Pharmaceuticals Inc
United States · RS rating 96 · As of 2026-10-14
| Price | 18.90 USD |
|---|---|
| 1-day change | -3.4% |
| RS rating (overall / 1M / 3M / 12M) | 96 / 95 / 80 / 95 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 55 / 54 / 75 |
| Industry group (rank) | Medical-Generic Drugs (94) |
| EPS growth Q/Q | +72.7% |
| Sales growth Q/Q | +3.8% |
| Distance from 52-week high | +7.8% |
| Market cap (USD) | $4.0B |